Table 4 |
|||
|
HER2 status by serum, CTC, and tissue |
|||
| Patient ID |
Serum HER2 |
HER2 CTC |
HER2 tissue |
|
|
|||
| #25 |
Negative |
ND |
Negative |
| #93 |
Negative |
ND |
Negative |
| #94 |
Negative |
ND |
Negative |
| #21 |
Negative |
ND |
Negative |
| #92 |
Negative |
ND |
Negative |
| #29 |
Negative |
ND |
Negative |
| #30 |
Negative |
ND |
Negative |
| #91 |
Positive |
Positive |
Negative |
| #12 |
Negative |
Negative |
Positive |
| #17 |
Positive |
Positive |
Positive |
|
|
|||
|
CTC, circulating tumor cell; HER, human epidermal growth factor receptor; ND, not detected. |
|||
|
Fehm et al. Breast Cancer Research 2007 9:R74 doi:10.1186/bcr1783 |
|||
